Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma

Figure 4

Survival of NSCLC patients and NMDAR2B gene methylation status. Kaplan-Meier curves of overall survival for 216 patients with lung cancer (A), 126 patients with adenocarcinoma (B) and 76 patients with squamous cell carcinoma (C). Patients with squamous cell carcinoma who had aberrantly methylated NMDAR2B genes had a significantly better survival rate compared with patients with unmethylated receptor genes (P = 0.002).

Back to article page